Clinical Trial Update: A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition [Phase 3]

View source ↗

Summary

Phase 3 study of HR19006 injection for postsurgical parenteral nutrition is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition-related Care

Drugs mentioned

• HR19006

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Parenteral Nutrition | Phase 3 | Status: UNKNOWN